223 related articles for article (PubMed ID: 3498588)
21. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
[TBL] [Abstract][Full Text] [Related]
22. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
24. DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.
Adu D; Dobson J; Williams DG
Clin Exp Immunol; 1981 Mar; 43(3):605-14. PubMed ID: 6974627
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosis.
Schiødt M; Permin H; Wiik A; Manthorpe R
Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):59-63. PubMed ID: 6603096
[TBL] [Abstract][Full Text] [Related]
26. Fine binding characteristics of human autoantibodies-partial molecular characterization.
Kumar S; Kalsi J; Bunting K; Ravirajan CT; Latchman DS; Pearl LH; Isenberg DA
Mol Immunol; 2004 Jul; 41(5):495-510. PubMed ID: 15183928
[TBL] [Abstract][Full Text] [Related]
27. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
28. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
Amoura Z; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
31. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.
Winfield JB; Faiferman I; Koffler D
J Clin Invest; 1977 Jan; 59(1):90-6. PubMed ID: 299748
[TBL] [Abstract][Full Text] [Related]
32. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
34. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies in systemic lupus erythematosus and normal subjects.
Pateraki E; Kaklamani E; Kaklamanis P; Portocalas R; Aessopos A
Clin Rheumatol; 1986 Sep; 5(3):338-45. PubMed ID: 3780141
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
37. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney.
Raz E; Brezis M; Rosenmann E; Eilat D
J Immunol; 1989 May; 142(9):3076-82. PubMed ID: 2785132
[TBL] [Abstract][Full Text] [Related]
38. Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes.
Termaat RM; Assmann KJ; van Son JP; Dijkman HB; Koene RA; Berden JH
Lab Invest; 1993 Feb; 68(2):164-73. PubMed ID: 7680080
[TBL] [Abstract][Full Text] [Related]
39. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
40. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]